Kyle Piskel - Oct 28, 2021 Form 3 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Principal Accounting Officer
Signature
/s/ Kyle Piskel by Eric Billings, Attorney in Fact
Stock symbol
ADPT
Transactions as of
Oct 28, 2021
Transactions value $
$0
Form type
3
Date filed
11/3/2021, 09:00 PM
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADPT Common Stock 2.86K Oct 28, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADPT Stock Option (Right to Buy) Oct 28, 2021 Common Stock 2.5K $6.32 Direct F1
holding ADPT Stock Option (Right to Buy) Oct 28, 2021 Common Stock 12K $6.55 Direct F2
holding ADPT Stock Option (Right to Buy) Oct 28, 2021 Common Stock 3.75K $7.80 Direct F3
holding ADPT Stock Option (Right to Buy) Oct 28, 2021 Common Stock 4.9K $27.29 Direct F4
holding ADPT Stock Option (Right to Buy) Oct 28, 2021 Common Stock 13.5K $28.32 Direct F5
holding ADPT Stock Option (Right to Buy) Oct 28, 2021 Common Stock 15K $45.82 Direct F6
holding ADPT Stock Option (Right to Buy) Oct 28, 2021 Common Stock 7.15K $43.68 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully vested.
F2 The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4 The options vested with respect to 1/4 of such shares on October 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5 The options vested with respect to 1/4 of such shares on February 27, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F6 The options vested with respect to 1/4 of such shares on September 24, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F7 The options vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

Remarks:

Mr. Piskel was designated Principal Accounting Officer on October 28, 2021.